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Summary
Autoimmune polyendocrinopathy type 1 (APS1) is an
autosomal recessive disorder characterized by autoim-
mune hypoparathyroidism, autoimmune adrenocortical
failure, and mucocutaneous candidiasis. Recently, an au-
toimmune regulator gene (AIRE-1), which is located on
chromosome 21q22.3, has been identified, and muta-
tions in European kindreds with APS1 have been de-
scribed. We used SSCP analysis and direct DNA se-
quencing to screen the entire 1,635-bp coding region of
AIRE-1 in 12 British families with APS1. A 13-bp de-
letion (964del13) was found to account for 17 of the
24 possible mutant AIRE-1 alleles, in our kindreds. This
mutation was found to occur de novo in one affected
subject. A common haplotype spanning the AIRE-1 lo-
cus was found in chromosomes that carried the 964del13
mutation, suggesting a founder effect in our population.
One of 576 normal subjects was also a heterozygous
carrier of the 964del13 mutation. Six other point mu-
tations were found in AIRE-1, including two 1-bp de-
letions, three missense mutations (R15L, L28P, and
Y90C), and a nonsense mutation (R257*). The high
frequency of the 964del13 allele and the clustering of
the other AIRE-1 mutations may allow rapid molecular
screening for APS1 in British kindreds. Furthermore, the
prevalence of the 964del13 AIRE-1 mutation may have
implications in the pathogenesis of the more common
autoimmune endocrinopathies in our population.
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Introduction
Organ-specific autoimmune diseases affect up to 4% of
the female population, over a lifetime, and are inherited
as complex multigenic traits (Vyse and Todd 1996). De-
spite the prevalence of these disorders and their well-
established genetic basis (Davies et al. 1994; Sawcer et
al. 1996), we have little knowledge of the molecular
pathways implicated in their pathogenesis. However, the
study of rare monogenic autoimmune syndromes may
provide insights for the investigation of the more com-
mon, genetically complex autoimmune disorders. One
such disorder is autoimmune lymphoproliferation syn-
drome (Canale and Smith 1967), in which inactivating
mutations of either the Fas or the Fas-L gene lead to a
failure of apoptotic elimination of activated peripheral
T lymphocytes (Fisher et al. 1995; Rieux-Laucat et al.
1995; Drappa et al. 1996; Wu et al. 1996). Another
inherited autoimmune syndrome is autoimmune polyen-
docrinopathy syndrome type 1 (APS1; MIM 240300),
which is also referred to as “autoimmune polyendocri-
nopathy with candidiasis and ectodermal dystrophy”
(Neufeld et al. 1981; Ahonen et al. 1990). APS1 is char-
acterized by the triad of autoimmune hypoparathyroid-
ism, autoimmune primary adrenocortical failure (Ad-
dison disease), and chronic mucocutaneous candidiasis
(Hung et al. 1963; Kenny and Holliday 1964; Arulan-
antham et al. 1979; Neufeld et al. 1981; Ahonen et al.
1990). Hypoparathyroidism and candidiasis generally
are manifest in affected subjects during childhood, with
the onset of adrenal failure typically in early adolescence.
Other autoimmune complications include type 1 dia-
betes mellitus, primary gonadal failure, pernicious ane-
mia, hepatitis, alopecia, vitiligo, and hypothyroidism
(Hung et al. 1963; Kenny and Holliday 1964; Arulan-
antham et al. 1979; Neufeld et al. 1981; Ahonen et al.
1990). Intestinal malabsorption, keratopathy, pitted nail
dystrophy, dental enamel hypoplasia, splenic atrophy,
gallstones, and oral carcinoma also may be present
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Figure 1 Pedigrees of the 12 kindreds with APS1. Males are represented by squares and females by circles. All affected subjects manifested
chronic mucocutaneous candidiasis. The presence of hypoparathyroidism, adrenal failure, type 1 diabetes, and/or primary gonadal failure is
indicated by different blackened quadrants in the subjects’ symbols (see key). Pernicious anemia was present in subjects II-2, family B; II-1,
family I; II-6, family K; and II-5, family L. Intestinal malabsorption was present in subjects II-2, family B; II-2, family G; II-1, family J; II-6,
family K; and II-5, family L. Chronic autoimmune hepatitis was present in subjects II-2, family B, and II-1, family D. Alopecia totalis was
present in subjects II-1, family F; II-1, family J; II-6, family K; and II-5, family L. Other autoimmune complications included hypothyroidism
(subject II-1, family F), ankylosing spondylitis (subject II-1, family B), and red-cell aplasia (subject II-2, family G). Keratopathy was present in
subjects II-1, family F, and II-6, family L. In addition, subject II-2, family G, manifested a squamous-cell carcinoma of his oral mucosa. Causes
of death for affected family members were b-hemolytic streptococcal septicemia (subject II-2, family B), postanesthetic adrenal crisis with
respiratory arrest (subject II-1, family C), fulminant hepatic failure (subject II-3, family E), systemic varicella infection (subject II-3, family K),
and intracerebral hemorrhage (subject II-5, family L). In addition, subject II-3, family G, who had previously had oral candidiasis, died suddenly
at age 6 years, during an episode of viral pneumonitis.
(Richman et al. 1975; Hong and Dibbell 1981; Neufeld
et al. 1981; Ahonen et al. 1990; Friedman et al. 1991).
APS1 is inherited as an autosomal recessive trait (Aho-
nen 1985) and is a rare disorder in most populations.
However, it has been estimated to occur in 1/25,000
people in Finland and in 1/9,000 Iranian Jews, because
of founder effects (Ahonen 1985; Zlotogora and Shapiro
1992). The founder effect in Finnish APS1 kindreds has
allowed the genetic mapping of APS1 to chromosome
21q22.3 and further refinement to a 350-kb region be-
tween markers D21S1912 and D21S1903, by linkage-
disequilibrium mapping (Aaltonen et al. 1994; Bjo¨rses
et al. 1996; Aaltonen et al. 1997). Subsequently, the
autoimmune regulator gene (AIRE-1) was identified in
this region, and six different AIRE-1 mutations have
been found in European APS1 kindreds (Finnish-
German APECED Consortium 1997; Nagamine et al.
1997). One particular nonsense mutation, R257*, was
found to account for 180% of mutant Finnish AIRE-1
alleles (Finnish-German APECED Consortium 1997;
Nagamine et al. 1997). One in 250 healthy people in
Finland were also found to be heterozygous carriers of
this nonsense AIRE-1 allele (Finnish-German APECED
Consortium 1997). AIRE-1 encodes a 545–amino acid
protein that has a nuclear localization signal and two
plant homeodomain (PHD)-type zinc-finger motifs (Aas-
land et al. 1995), suggesting a role as a transcription
factor (Finnish-German APECED Consortium 1997;
Nagamine et al. 1997). Five of the sixAIRE-1mutations
predicted a truncation of the protein, which is consistent
with a loss of AIRE-1 function, leading to APS1 (Finnish-
German APECED Consortium 1997; Nagamine et al.
1997). However, the exact role of AIRE-1 in regulating
immune responses remains obscure. In this study, we
performed a mutation analysis of AIRE-1 in British
APS1 kindreds, to define the spectrum of AIRE-1 mu-
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Table 1
Primer Sequences and Conditions for Amplification of AIRE-1
Exon Primer Sequencesa
Size of
Product
(bp)
Annealing
Temperature
(C)
1 F: AAGCGAGGGGCTGCCAGTGTC 258 65
R: GGGACTATCCCTGGCTCACAG
2 F: TCCACCACAAGCCGAGGAGAT 389 62
R: AGCTGGGCTGAGCAGGTGACA
3 F: CTGAGGTTGGGACCCTGCTCC 231 63
R: CTGGAGACCCTGGCTGGCTTC
4 F: GGCACTCACCCCCACTGAGAG 202 63
R: GCCCTGCTCTGACCCCTGAC
5 F: GCCCAGTGCTGCCTGCTTCTG 256 63
R: CCATCTTGGAGCCTGGGTCTC
6 F: TGCAGGCTGTGGGAACTCCAC 303 59
R: GGGGCATCAAGAGCCAGGCTC
7 F: CATGTCCACCCTCGCTGCTGA 278 63
R: AGAAAAAGAGCTGTACCCTGTGG
8 F: CACCCCAGCCCAGTCTGCATG 229 63
R: CTTCAGGGTCAGTGGGTGGAG
9 F: CTGTCACCCGCTCTGTTGTTC 205 63
R: GTGGCCATGTGGACAGGAGG
10 F: CCCAGCAGTCACTGACTCCTG 311 62
R: CGTAGGTCCTGGGCTCCTTGA
11 F: CTCGGGTTCGGGTTCAGCTAC 233 63
R: TGTGGGTGTGGGTTCAGGCCT
12 F: CATACCCCGGAGGTGGCACTC 205 64
R: CAGCACCGGCATGCATGGAGG
13 F: CTGTGGGAGTTGGGCTGACCT 141 60
R: AGTGGAGGAGCACCAGGAGG
14 F: ATGGCCATGATTGTGTGGCTG 188 59
R: CTCAGCACTCTCTCATCAGAG
a F  forward, and R  reverse.
tations in our population and to allow a molecular ge-
netic screening strategy for predictive use in apparently
unaffected siblings from APS1 kindreds.
Patients and Methods
Patients
Twelve nonconsanguineous sibships with at least one
affected APS1 member were identified, and paraffin-em-
bedded material or blood samples were obtained from
a total of 43 (16 affected and 27 unaffected) kindred
members. All affected members had chronic mucocu-
taneous candidiasis, with an age at first onset between
18 mo and 21 years. Details of the other clinical man-
ifestations are shown in figure 1. The clinical details for
subject II-1 from family B have been reported elsewhere
(Kendall-Taylor et al. 1988). Studies were performed
with the informed consent of each subject and with the
approval of the regional ethics committee.
DNA Extraction and SSCP Analysis
DNA from leukocytes and paraffin-embedded sections
was prepared by SDS lysis, proteinase K digestion, and
phenol-chloroform extraction, in accordance with stan-
dard methods. Genomic DNA from the proband of each
family and from four unrelated normal individuals was
used as a template for PCR with oligonucleotide primers
(table 1) that encompassed each of the 14 exons and the
26 splice sites of AIRE-1. PCR was performed with 200
ng template DNA, 50 pmol of each primer, 200 mM
dNTPs, 1 mM MgCl2, 50 mM KCl,10 mM Tris-HCl
(pH 8.3), and 1 U Taq DNA polymerase (Gibco BRL),
in a final volume of 50 ml. After an initial denaturation
at 94C for 5 min, 35 cycles of PCR amplification were
performed, with each cycle consisting of 30 s at 93C,
30 s at a primer pair–dependent annealing temperature
(see table 1), and 30 s at 72C. After 35 cycles, a final
DNA extension step at 72C for 5 min was performed.
PCR products were analyzed for SSCPs by use of precast
12.5% polyacrylamide gels run on the Phast minigel
electrophoresis system (Pharmacia LKB). Gels were run
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Table 2
AIRE-1 Mutations in British APS1 Families
Kindred Exon Positiona Nucleotide Change Amino Acid Change Confirmed byb
A 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
B 10 1264 1-bp deletion 478-residue truncation Bsu36I
8 964 13-bp deletion 372-residue truncation BsrBI
C 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
D 1 44 CGGrCTG Arg15Leu BcgI
8 964 13-bp deletion 372-residue truncation BsrBI
E 6 768 CGArTGA Arg257Stop TaqI
2 271 TATrTGT Tyr90Cys ASO
F 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
G 1 83 CTGrCCG Leu28Pro MspAI
10 1249 1-bp deletion 478-residue truncation ASO
H 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
I 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
J 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
K 8 964 13-bp deletion 372-residue truncation BsrBI
8 964 13-bp deletion 372-residue truncation BsrBI
L 8 964 13-bp deletion 372-residue truncation BsrBI
NOTE.—Data for paternally inherited mutations are shown above those for the maternal mu-
tation, for each proband from families A–H (fig. 1).
a Nucleotides are numbered from the first position of the initiator methionine codon.
b The restriction enzyme is given for those mutations confirmed by restriction-enzymedigestion.
for 150–185 V-h, at a temperature of 10C. The gels
then were fixed and stained with 0.4% silver nitrate, as
described elsewhere (Pearce et al. 1995).
DNA Sequence Analysis
Twenty microliters of each of the PCR products that
gave an abnormal SSCP pattern were gel purified in a
1.5% agarose gel, and the DNA sequence of both strands
was determined by Taq polymerase cycle sequencing
with fluorochrome-labeled dideoxy terminators resolved
by a laser detection system (373A sequencer, Applied
Biosystems). For the analysis of heterozygous deletions,
the abnormal PCR product was cloned into the pGEMT-
easy vector (Promega), and five clones were sequenced
from M13 primers. Each DNA sequence abnormality
was confirmed to be present either by restriction-enzyme
analysis or by allele-specific oligonucleotide (ASO) hy-
bridization to wild-type and mutant sequence, 32P–end
labeled oligonucleotides, as described elsewhere (Pearce
et al. 1995). In addition, either restriction-enzyme anal-
ysis or ASO was used to screen DNA from other affected
and unaffected family members and from 56 unrelated
healthy subjects. All nucleotide sequences were num-
bered from the first position of the initiator methionine
codon of the AIRE-1 sequence (GenBank accession
number z97990).
Microsatellite Polymorphism Analysis
Six microsatel l i te polymorphisms (D21S49,
D21S1890, D21S1912, PFKL, D21S171, and
D21S1903), which span a 2-cM region flanking AIRE-
1 (Dib et al. 1996; Aaltonen et al. 1997), were typed in
the nine kindreds with available parents, by use of meth-
ods described elsewhere (Pearce et al. 1995). The anal-
ysis of allelic association at the PFKL locus was
performed by use of the Yates-corrected x2 test.
Ten microsatellite markers (D2S116, CTLA4[AT]n,
D2S2289, D14S267, D14S68, D14S74, D14S70,
D14S72, D14S51, and D14S1054 [Dib et al. 1996; Nis-
tico et al. 1996]), each with eight or more alleles and a
heterozygosity 170%, were used to exclude nonpatern-
ity, as described elsewhere (Pearce et al. 1995).
Results
SSCP analysis of the PCR products encompassing all
14 exons and 26 splice junctions of AIRE-1 (table 1)
was performed on each APS1 proband, followed by di-
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Figure 2 Demonstration of the 13-bp deletion (964del13) at nucleotide 964 in families A and B, by use of restriction enzyme BsrBI. a,
Wild-type and mutant (964del13) DNA sequences. The deletion abolishes the recognition site (CCG/CTC) for the restriction enzyme BsrBI,
shown above the wild-type sequence. b, Restriction map of the wild-type and mutant PCR products with restriction enzyme BsrBI. c, Results
of PCR amplification of exon 8 followed by BsrBI digestion in families A and B. Subject II-1 from family A has the mutant 216-bp band and
neither of the wild-type 140- or 89-bp products, demonstrating that he is homozygous for the 13-bp deletion. His mother, I-2, can be seen to
be heterozygous for this deletion, with each of the 216-, 140-, and 89-bp products present. In contrast, his father, I-1, has only the wild-type
140- and 89-bp products. Because paternity could not be refuted by the analysis of 14 microsatellite polymorphisms, the mutation in the paternal
allele in subject II-1 from family A was determined to be a de novo mutation. The 964del13 mutation also was determined to be heterozygous
in subjects II-1 and II-2 from family B, who are affected with APS1, and in their mother, I-2. Their unaffected younger sister, II-3, and three
unrelated normal subjects (N1–N3) have only the wild-type digestion products. This method also was used to confirm the presence of the
964del13 mutation in affected members of families C, D, F, and H–L (table 2).
rect DNA sequence analysis of any product with an
abnormal SSCP pattern. This strategy allowed the iden-
tification of 23 AIRE-1 mutations in the 12 APS1 pro-
bands (table 2).
Deletions
A 13-bp deletion at nucleotide 964 in exon 8 was
found to be present in 10 of the APS1 probands. This
deletion (964del13) abolished aBsrBI restriction-enzyme
site (fig. 2), and this was used to demonstrate that the
deletion was homozygous in seven APS1 probands and
heterozygous in three affected subjects (table 2). Thus,
964del13 accounted for 17 of the 24 possible mutant
AIRE-1 alleles in our families. Screening for 964del13
in DNA from a total of 576 unrelated control subjects
with BsrBI showed one heterozygous carrier of the de-
letion, which predicts a truncated AIRE-1 protein of only
372 amino acids.
The 964del13 mutation appeared to be homozygous
in subject II-1 from family A, and his mother (I-2) was
found to be a heterozygous carrier (fig. 2). However, his
father (I-1) did not carry this mutation in his leukocyte
DNA (fig. 2). Similarly, his youngest brother, II-3, who
also had inherited the “affected” paternal haplotype
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Figure 3 Tyrosine to cysteine missense mutation at codon 90 in family E. a, Wild-type DNA sequence chromatogram, from codons 89–91
in exon 2 of AIRE-1, with the mutant heterozygous ArG transition found in subject II-2 shown in the lower box. b, Hybridization of 32P-
labeled ASO to dot-blotted exon 2 PCR products from members of family E and from three unrelated normal controls (N1–N3). The hybridization
signal is present in all samples with the wild-type oligonucleotide; however, in the samples with the mutant (Y90C) oligonucleotide, hybridization
is seen only for subjects I-2 and II-2 from family E. This demonstrates that the Y90C mutation is heterozygous in subjects I-2 and II-2. The
Y90C mutation was not found in the unaffected sister of the proband (II-1) or in 56 normal controls, of whom the results for N1–N3 are shown.
(data not shown), did not carry the 964del13 allele.
Nonpaternity was excluded by the demonstration of al-
lele sharing between father and son, at the six micro-
satellite polymorphisms flanking AIRE-1 and at an ad-
ditional 10 highly polymorphic markers. These findings
demonstrate that, in family A, the 964del13 mutation
had occurred de novo in the paternally inherited AIRE-
1 allele.
Two heterozygous 1-bp deletions were found in
exon 10, at nucleotides 1249 (1249delC) and 1264
(1264delC), in the probands of families G and B, re-
spectively (table 2). Neither of these 1-bp deletions,
which both predicted premature AIRE-1 truncations,
was found in 56 unrelated control subjects without au-
toimmune disease.
Nonsense Mutations
The nonsense mutation in exon 6, R257*
(CGArTGA), which is the founder Finnish AIRE-1mu-
tation (Finnish-German APECED Consortium 1997;
Nagamine et al. 1997), was found in the proband of
family E (table 2). This family could not trace any Finn-
ish ancestry. This nonsense mutation predicted a trun-
cated AIRE-1 protein of 256 amino acids and eliminated
a TaqI restriction-enzyme site, which was used to con-
firm its heterozygosity in the proband of this family. The
TaqI digestion assay was used to demonstrate that the
R257* mutation was not present in DNA from 56 con-
trol subjects.
Missense Mutations
The proband of family D (II-1) was found to be het-
erozygous for a GrT transversion at nucleotide 44. This
base change predicted the missense mutation R15L
(CGCrCTC) and abolished a BcgI restriction-enzyme
site in exon 1, which was used to demonstrate that his
apparently unaffected sister (II-2) also carried this mu-
tation. The proband of family G was found to be het-
erozygous for a TrC transition at nucleotide 83, pre-
dicting the missense mutation L28P (CTGrCCG) and
creating an MspAI restriction-enzyme site. Subject II-2
from family E was found to have an ArG transition at
nucleotide 269, predicting a Y90C (TATrTGT) mis-
sense mutation (fig. 3). ASO was used to confirm the
presence of this mutation and to demonstrate its ma-
ternal inheritance (fig. 3). Each of these missense mu-
tations predicted a significant change in the amino acid
sequence and was demonstrated not to be present in
DNA from 56 unrelated control subjects, by use of either
restriction-enzyme digestion (R15L and L28P) or ASO
(Y90C).
Noncoding Polymorphisms
Polymorphisms that did not code for an amino acid
change were found at nucleotide 517 (codon 196) in
exon 5 (TCCrTCT) in 40% of alleles and at the nu-
cleotide position 5 from the donor splice site of exon
9 (GGtatggcrGGtatgac) in 8% of alleles.
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Figure 4 Chromosome 21q22.3 haplotypes and corresponding AIRE-1 mutation in the nine affected kindreds (A–I; fig. 1) for which at
least one parent was available for study. The marker order is given on the top line, with sex-averaged genetic distances given on the bottom
line (Bjorses et al. 1996; Dib et al. 1996; Aaltonen et al. 1997). AIRE-1 is located between D21S1912 and PFKL. Haplotypes are designated
by family and by the paternal (P) or maternal (M) transmission. The dagger symbol (†) denotes the de novo origin of the 964del13 mutation
on the paternal haplotype of family A (A/P). The common haplotype (4-3-3-7) for markers D211912, PFKL, D21S171, and D21S1903 in the
964del13-carrying chromosomes is boxed.
Chromosome 21q22.3 Haplotype Analysis
The haplotypes over a 2-cM region of chromosome
21q22.3, encompassing AIRE-1, were determined in the
nine families who had one or more parents available
for study. The marker order and genetic distances were
as follows: cen–D21S49–0.95 cM–D21S1890–0.6
cM–D21S1912–0.15 cM–(AIRE-1)–PFKL–0.2 cM–
D21S171–0.1 cM–D21S1903–tel, with PFKL being
within 20 kb of AIRE-1 (Finnish-German APECED
Consortium 1997; Nagamine et al. 1997). Eleven of
these 18 affected haplotypes occurred in associationwith
a transmitted 963del13 allele, and a partially conserved
common haplotype, over a 0.45-cM region between
markers D21S1912 and D21S1903, was observed in
these affected chromosomes (fig. 4). In addition to these
11 964del13 haplotypes, which all carried allele 3 at the
PFKL locus (fig. 4), the probands of families J, K, and
L also were found to be homozygous for allele 3 at the
PFKL locus. Thus, all 16 of the 964del13 mutations
transmitted from the parental germ line were associated
with allele 3 at PFKL, compared with 55 (56%) of 98
unrelated control alleles ( , ).2x  9.48 P  .002
Discussion
AIRE-1 Mutation Spectrum
Our study has identified AIRE-1 mutations in each of
12 probands with APS1, which confirms the genetic ho-
mogeneity of this disorder in our population. Of the total
of 23 mutant AIRE-1 alleles found, there were seven
different mutations, five of which are novel. Each mu-
tation either predicts a premature truncation of the
AIRE-1 protein or a significant amino acid change, and,
with the exception of the 964del13 allele, none were
found in 150 unrelated normal subjects. When consid-
ering together the mutations found in our population
with the six AIRE-1 mutations described elsewhere
(Finnish-German APECED Consortium 1997; Naga-
mine et al. 1997), we noted that the four missense mu-
tations (R15L, L28P, K83E, and Y90C) all cluster in the
amino-terminal region of AIRE-1, encoded by exons 1
and 2 (fig. 5). The AIRE-1 protein is predicted to contain
two PHD-type zinc-finger domains (Aasland et al. 1995),
encoded by exons 8 and 9 and exons 11 and 12 (fig. 5);
therefore, the AIRE-1 protein has been proposed to act
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Figure 5 Schematic diagram of the genomic structure of AIRE-1 and locations of the mutations found in the British APS1 subjects and
of those reported previously (Finnish-German APECED Consortium 1997; Nagamine et al. 1997). The exon number is shown above each box,
and the size of each exon is given inside each box. The regions encoding the two PHD-type zinc-finger domains are hatched, with the proline-
rich region shaded. The missense mutations are shown to occur in exon 1 or 2. The common Finnish mutation R257*, which was also found
in family E (table 2), is shown in exon 6. The common British mutation 964del13 is shown in exon 8, with the adjacent insertion at nucleotide
965 (965ins4). The remainder of the mutations, which are either 1-bp deletions or insertions, were all found in exon 10. The amino acids are
designated by conventional single-letter codes.
as a transcription factor (Finnish-German APECED
Consortium 1997; Nagamine et al. 1997). These clus-
tered missense mutations in the amino terminus of the
protein possibly act to disrupt binding of the currently
undefined ligand. The remainder of the mutations are
found in exon 6, 8, or 10, and each of these mutations,
if translated, would predict a nonfunctional AIRE-1 pro-
tein that would lack either one or both of the putative
zinc-finger domains. The observation that all of the 11
mutations thus far found in APS1 subjects cluster into
5 of the 14 exons of AIRE-1 provides useful information
for future molecular genetic screening of APS1 families
(fig. 5).
Clinical Applications
We studied four apparently unaffected subjects who
were !16 years of age and who were siblings of an APS1
proband (subjects II-2 and II-3 from family A, subject
II-2 from family D, and subject II-2 from family F). These
children had an ∼25% risk of developing APS1 in the
future (Ahonen 1985; Ahonen et al. 1990). Haplotype
analysis, subsequently confirmed by mutation analysis,
was able to demonstrate that the unaffected siblings in
families A (fig. 2) and F did not carry either mutant
AIRE-1 allele, and we have stopped regular dynamic
screening for primary adrenal failure in these children.
The 13-year-old sister (II-2) of the proband (II-1) from
family D, however, carried both affected chromosome
21q22.3 haplotypes and was found to carry the same
AIRE-1 mutations (R15L and 964del13) as her brother.
We intensified her screening program accordingly, and
she was found to have dental enamel hypoplasia and
subsequently developed hypocalcemia, which is indica-
tive of hypoparathyroidism. Thus, we were able to pre-
dict her high risk of developing APS1 (Ahonen 1985).
Twenty of the 23 mutations present in our APS1 sub-
jects predict a nonfunctional AIRE-1 protein. However,
three APS1 subjects (the probands of families D, E, and
G) have one missense mutation that may lead to a dim-
inution, rather than a total abrogation, of AIRE-1 func-
tion. Of these three subjects, two (II-2 from family E
and II-2 from family G) have not manifested adrenal
failure or hypoparathyroidism, at the ages of 30 years
and 33 years, respectively. Although this is a small num-
ber of patients, it suggests that there may be a genotype-
phenotype correlation for the spectrum of clinical man-
ifestation of for the age at onset of the autoimmune
manifestations of APS1.
Mutation Prevalence and Pathogenesis
The finding that the 13-bp deletion in exon 8
(964del13) accounts for 17 (71%) of a possible 24 mu-
tant alleles in our population was initially unexpected.
However, the demonstration that 964del13 had a pop-
ulation frequency of 1/576 healthy subjects shows that
it is an infrequently carried heterozygous mutation in
the British population. The novel observation of this
mutation as a de novo event in the paternal allele of
family A (fig. 2) shows that it is also recurrent in this
case. The DNA sequence surrounding nucleotide 964
(CCTGGCCTGCCTG) contains two different repetitive
sequences (fig. 2)—namely, three repeats of a CCTG se-
quence and two overlapping repeats of a GCCTG se-
quence, with the G at nucleotide 964 forming the over-
lap. These repetitive sequences may predispose to
slipped-strand mispairing (Farabaugh et al. 1978; Fu-
Pearce et al.: AIRE-1 Mutations in APS1 1683
kuhara et al. 1990), resulting in the high frequency of
the 964del13 mutation that we observed and in the oc-
currence of the 4-bp insertion (CCTG) at nucleotide
965 that had been found previously (Finnish-German
APECED Consortium 1997).
The common haplotype observed in chromosomes
carrying the 964del13 mutation (fig. 4) and the strong
association of allele 3 of the PFKL locus suggests that
there is a founder effect for this mutation in our pop-
ulation. Linkage disequilibrium in ancient populations
may be found over localized chromosomal regions of
100 kb (de la Chapelle 1993; Hastabacka et al. 1994;
Houwen et al. 1994; Jorde 1995), and the PFKL locus
is within 20 kb of the 964del13 mutation (Finnish-
German APECED Consortium 1997; Nagamine et al.
1997). Thus, the 964del13 AIRE-1 allele appears to be
present in our population because of a combination of
recurrent mutation (as seen in family A) and an ancient
founder effect. The finding of this common AIRE-1 de-
letion in our APS1 patients has implications for popu-
lations such as Anglo-Americans, who have, in part,
common ancestry with the British population. Further-
more, this deletion, which is carried infrequently as a
heterozygous allele, may be important in the pathogen-
esis of the more common autoimmune endocrinopathies
(Vyse and Todd 1996) or of chronic mucocutaneous
candidiasis.
Note added in proof.—Scott et al. (1998) have re-
cently made findings complementary to those of this
study.
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